GENLISA Fructose 1,6 diphosphate aldolase (FDA) Assay Kit

Fructose 1,6 diphosphate aldolase (FDA) is a key component of cellular glucose metabolism and is routinely studied to understand glycolytic flux, energy balance, and metabolic reprogramming in cancer and immune cells. This microplate-based assay kit is designed for convenient measurement of Fructose 1,6 diphosphate aldolase (FDA) activity in biological samples such as cell and tissue lysates, cultured cells, and other research matrices. Enzyme activity measurements are useful for pathway mapping, inhibitor screening, functional validation, and comparing metabolic states across experimental conditions. The assay is supplied with ready-to-use reagents and a straightforward workflow that generates a measurable signal proportional to analyte level or activity, compatible with standard microplate readers. Typical applications include metabolic pathway studies, stress-response research, pharmacology/toxicology screening, and functional characterization of engineered cells or disease models. For research use only (RUO) .